The federal government is moving toward a unified national approach to AI regulation – and health care and life sciences…
Read More →
Meningioma brain tumors are often described as slow-growing and benign. But for many patients, the effects are anything but minor.…
Read More →
Recently, I attended the 2026 Perrin Conferences PFAS Litigation and Regulatory Developments Conference, where industry leaders and practitioners explored the…
Read More →
Dupixent (dupilumab) has been a genuine breakthrough for many families. For children with moderate-to-severe eczema, asthma, and other inflammatory conditions,…
Read More →
Effective January 1, 2027, many California employers must comply with a challenging and detailed set of new requirements before using…
Read More →
Can AI-Generated Legal Drafts Be Protected as Work Product? As the use of artificial intelligence (AI) continues to accelerate across…
Read More →
I’m a huge fan of monster movies, especially all things Titan related. Whether it’s Godzilla stomping all over cities, King Kong beating his chest or…
Read More →
Regulators worldwide are grappling with how to address the alleged risks artificial intelligence (“AI”)-powered chatbots and virtual companions pose, including…
Read More →
Artificial intelligence and advanced digital tools are no longer experimental on construction projects. In Q1 of 2026, we can already…
Read More →